215 related articles for article (PubMed ID: 21603308)
1. Autograft mediated adoptive immunotherapy of cancer in the context of autologous stem cell transplantation.
Porrata LF; Markovic SN
World J Clin Oncol; 2010 Nov; 1(1):29-34. PubMed ID: 21603308
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Infused Autograft Absolute Numbers of Immune Effector Cells on Survival Post-Autologous Stem Cell Transplantation.
Porrata LF
Cells; 2022 Jul; 11(14):. PubMed ID: 35883639
[TBL] [Abstract][Full Text] [Related]
3. Autologous Graft-versus-Tumor Effect: Reality or Fiction?
Porrata LF
Adv Hematol; 2016; 2016():5385972. PubMed ID: 27635143
[TBL] [Abstract][Full Text] [Related]
4. Autograft immune effector cells and survival in autologous peripheral blood hematopoietic stem cell transplantation.
Porrata LF
J Clin Apher; 2018 Jun; 33(3):324-330. PubMed ID: 29232011
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic cell-mediated and cytokine-activated immunotherapy for malignant lymphoma at the stage of minimal residual disease after autologous stem cell transplantation.
Or R; Ackerstein A; Nagler A; Amar A; Naparstek E; Varadi G; Kapelushnik J; Samuel S; Pugatsch T; Brautbar C; Slavin S
J Immunother; 1998 Nov; 21(6):447-53. PubMed ID: 9807740
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic cell-mediated immunotherapy at the stage of minimal residual disease following high-dose chemotherapy supported by autologous stem cell transplantation.
Slavin S
Acta Haematol; 2005; 114(4):214-20. PubMed ID: 16269861
[TBL] [Abstract][Full Text] [Related]
8. Autologous Stem Cell Transplantation for Myeloma: Cytoreduction or an Immunotherapy?
Minnie SA; Hill GR
Front Immunol; 2021; 12():651288. PubMed ID: 33777050
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic cell-mediated immunotherapy for breast cancer after autologous stem cell transplantation: a clinical pilot study.
Or R; Ackerstein A; Nagler A; Kapelushnik J; Naparstek E; Samuel S; Amar A; Bruatbar C; Slavin S
Cytokines Cell Mol Ther; 1998 Mar; 4(1):1-6. PubMed ID: 9557210
[TBL] [Abstract][Full Text] [Related]
10. Donor lymphocyte infusion: the use of alloreactive and tumor-reactive lymphocytes for immunotherapy of malignant and nonmalignant diseases in conjunction with allogeneic stem cell transplantation.
Slavin S; Morecki S; Weiss L; Or R
J Hematother Stem Cell Res; 2002 Apr; 11(2):265-76. PubMed ID: 11983098
[TBL] [Abstract][Full Text] [Related]
11. Autologous and allogeneic hematopoietic stem cell transplantation in follicular lymphoma.
Bhatt VR; Armitage JO
Expert Opin Biol Ther; 2016; 16(1):57-66. PubMed ID: 26515478
[TBL] [Abstract][Full Text] [Related]
12. Non-myeloablative stem cell transplantation for the treatment of cancer and life-threatening non-malignant disorders; past accomplishments and future goals.
Slavin S; Aker M; Shapira MY; Panigrahi S; Gabriel C; Or R
Transfus Apher Sci; 2002 Oct; 27(2):159-66. PubMed ID: 12350051
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation.
Tsai T; Goodman S; Saez R; Schiller G; Adkins D; Callander N; Wolff S; Freytes CO
Bone Marrow Transplant; 1997 Nov; 20(10):859-63. PubMed ID: 9404927
[TBL] [Abstract][Full Text] [Related]
14. [Allogeneic hematopoietic stem cell transplantation for solid tumors in the United States: a review].
Cheng YC; Ueno NT
Nihon Rinsho; 2003 Sep; 61(9):1619-34. PubMed ID: 14515734
[TBL] [Abstract][Full Text] [Related]
15. Introducing graft-versus-leukemia into autologous stem cell transplantation.
Klingemann HG
J Hematother; 1995 Aug; 4(4):261-7. PubMed ID: 7489140
[TBL] [Abstract][Full Text] [Related]
16. Nonmyeloablative stem cell transplantation for the treatment of cancer and life-threatening nonmalignant disorders: past accomplishments and future goals.
Slavin S; Or R; Aker M; Shapira MY; Panigrahi S; Symeonidis A; Cividalli G; Nagler A
Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S79-84. PubMed ID: 11587373
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow transplantation: a new strategy for intractable diseases.
Ikehara S
Drugs Today (Barc); 2002 Feb; 38(2):103-11. PubMed ID: 12532188
[TBL] [Abstract][Full Text] [Related]
18. Conventional hematopoietic stem cell transplants from identical or alternative donors are feasible in recipients relapsing after an autograft.
di Grazia C; Raiola AM; Van Lint MT; Lamparelli T; Gualandi F; Berisso G; Bregante S; Dominietto A; Mordini N; Bruno B; Frassoni F; Bacigalupo A
Haematologica; 2001 Jun; 86(6):646-51. PubMed ID: 11418375
[TBL] [Abstract][Full Text] [Related]
19. Autologous and allogeneic stem cell transplantation in follicular lymphoma.
Van Besien K
Transfus Apher Sci; 2005 Feb; 32(1):45-53. PubMed ID: 15737873
[TBL] [Abstract][Full Text] [Related]
20. Augmenting Autologous Stem Cell Transplantation to Improve Outcomes in Myeloma.
Maybury B; Cook G; Pratt G; Yong K; Ramasamy K
Biol Blood Marrow Transplant; 2016 Nov; 22(11):1926-1937. PubMed ID: 27288955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
